Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients
Laminin-211 deficiency leads to the most common form of congenital muscular dystrophy in childhood, MDC1A. The clinical picture is characterized by severe muscle weakness, brain abnormalities and delayed motor milestones defining MDC1A as one of the most severe forms of congenital muscular diseases....
Main Authors: | Heike Kölbel, Denisa Hathazi, Matthew Jennings, Rita Horvath, Andreas Roos, Ulrike Schara |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00470/full |
Similar Items
-
A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD
by: Kinga I. Gawlik, et al.
Published: (2020-04-01) -
Occipital cortex dysgenesis with white matter changes due to mutations in Laminin a2
by: Uluç Yiş, et al.
Published: (2017-06-01) -
Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
by: Pamela Barraza-Flores, et al.
Published: (2020-06-01) -
Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A
by: Davin Packer, et al.
Published: (2021-06-01) -
Antioxidants Reduce Muscular Dystrophy in the <i>dy<sup>2J</sup>/dy<sup>2J</sup></i> Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
by: Vahid M. Harandi, et al.
Published: (2020-03-01)